Integrated Clinical and Genomic Models to Predict Optimal Cytoreduction in High-Grade Serous Ovarian Cancer

SIMPLE SUMMARY: Approximately 30% of patients with advanced, high-grade serous ovarian cancer who undergo surgery will have a suboptimal result, resulting in decreased overall survival. Improving the ability to predict a successful surgery would improve survival. We aimed to use tumor genomics to cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardillo, Nicholas, Devor, Eric J., Pedra Nobre, Silvana, Newtson, Andreea, Leslie, Kimberly, Bender, David P., Smith, Brian J., Goodheart, Michael J., Gonzalez-Bosquet, Jesus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323510/
https://www.ncbi.nlm.nih.gov/pubmed/35884615
http://dx.doi.org/10.3390/cancers14143554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323510/
https://www.ncbi.nlm.nih.gov/pubmed/35884615
http://dx.doi.org/10.3390/cancers14143554

Ejemplares similares